Subgroup analysis claims in haematologic phase III trials lack credibility, says study
The credibility of subgroup claims found in haematology randomized clinical trials (RCTs) seems to be lacking even when the claims are robust, suggests a study, noting that information about subgroup difference must be interpreted with caution.
Subgroup analysis claims in haematologic phase III trials lack credibility, says study
21 Jul 2021
